Wang Changlu
Hunan Normal University
7 Papers
3 Citations
Wang Changlu is an academic researcher from Hunan Normal University. The author has contributed to research in topics: Balloon & Reperfusion injury. The author has an hindex of 2, co-authored 7 publications.
Chat about Author
Papers
Long non-coding RNA KCNQ1OT1/microRNA-204-5p/LGALS3 axis regulates myocardial ischemia/reperfusion injury in mice
Jingjing Rong,Hongwei Pan,Jin He,Yu Zhang,Yongjun Hu,Wang Changlu,Qinghua Fu,Wenjuan Fan,Qiong-Chao Zou,Le Zhang,Yi Tang,Xiang Peng,Peng Wang,Yuanyuan Xiang,Jianqiang Peng,Liu Zhengyu,Zhaofen Zheng +16 more
TL;DR: It is shown that KCNQ1OT1 binds to miR-204-5p to exacerbate myocardial IR injury in mice through the up-regulation of LGALS3, providing a novel insight for myocardIAL IR injury treatment.
41
Downregulated microRNA-330 suppresses left ventricular remodeling via the TGF-β1/Smad3 signaling pathway by targeting SRY in mice with myocardial ischemia-reperfusion injury.
Liu Zhengyu,Hongwei Pan,Yan Cao,Jiao Zheng,Yu Zhang,Yi Tang,Jin He,Yongjun Hu,Wang Changlu,Qiong-Chao Zou,Qinghua Fu,Le Zhang,Jianqiang Peng,Jing Ling,Ning Peng,Jingjing Rong,Zhaofen Zheng +16 more
TL;DR: It is demonstrated that downregulated miR‐330 could suppress left ventricular remodeling to inhibit the activation of the TGF‐β1/Smad3 signaling pathway via negatively targeting of SRY in mice with MIRI.
17
Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction and chronic kidney disease.
Liu Zhengyu,Zi-Hui Yin,Liang Chengyang,Jing He,Wang Changlu,Xiang Peng,Yu Zhang,Zhaofen Zheng,Hongwei Pan +8 more
TL;DR: In this article, ultra-low volume contrast percutaneous coronary intervention (PCI) was performed after minimal contrast coronary angiography using zero contrast optical coherence tomography (OCT) guidance.
6
Patent
Ischemia reperfusion balloon with controllable in-vivo flow
Li Dandan,Li Feng,He Ximei,Zhou Jinhua,Tan Boyu,Long Yuting,Qiong-Chao Zou,Qinghua Fu,Zhou Yani,Liang Chengyang,Xie Jiao,Jin He,Wang Changlu,Yu Zhang,Yan Cao,Liu Zhengyu,Hongwei Pan,Zhaofen Zheng,Yu Dengfeng +18 more
- 20 Sep 2019
TL;DR: In this article, an ischemia reperfusion balloon with controllable in-vivo flow is presented. But the balloon only needs to be expanded and released once while the far end is perfused, so that vascular injury, plaque shedding and no regurgitation of the far-end blood vessel can be reduced or avoided.
1
Patent
In-vitro-input-controllable balloon capable of reducing ischemia reperfusion injury
Yan Cao,Xie Jiao,Yu Zhang,Tan Boyu,Chen Huali,Xiaoying Qiu,Wang Changlu,Jin He,Liu Zhengyu,Hongwei Pan,Zhaofen Zheng +10 more
- 07 Dec 2018
TL;DR: In this article, an in-vivo-flow-controllable balloon capable of reducing the ischemia reperfusion injury is presented, where the balloon only needs one time of expansion and release while the distal end is subjected to perfusion, and blood vessel injuring, plaque falling, and distal blood-vessel no-reflowing phenomenon can be reduced or avoided.